Yazici Yusuf, Steiger Benjamin
Seligman Center, Department of Rheumatology and Medicine, NYU Hospital for Joint Diseases, 246 East 20th Street, Suite 101, New York, NY 10003, USA.
Bull NYU Hosp Jt Dis. 2012;70(3):204-7.
Kinase inhibitors have now been shown to work in various types of patients and have potential to be additional weapons in our armamentarium in rheumatoid arthritis treatment. This review will go over the currently available data and discuss potential uses for these new agents.
激酶抑制剂现已被证明对各类患者有效,并且有可能成为我们类风湿关节炎治疗手段中的新武器。本综述将梳理当前可得的数据,并讨论这些新药的潜在用途。